An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric Study Participants With Generalized Myasthenia Gravis
Clinical trial NCT06540144 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06540144
- Sponsor
- UCB Biopharma SRL
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-08
- Primary completion
- 2027-08-17
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.